Evidence map›Paper›PMID 34732768›Full record

ArticleScientific reports2021

Estimating DNA methylation potential energy landscapes from nanopore sequencing data.

Jordi Abante, Sandeep Kambhampati, Andrew P Feinberg, John Goutsias

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jordi AbanteWhitaker Biomedical Engineering Institute, Johns Hopkins University, Baltimore, MD, 21218, USA. jabante@stanford.edu.
Sandeep KambhampatiDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21205, USA.
Andrew P FeinbergDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21205, USA.
John GoutsiasWhitaker Biomedical Engineering Institute, Johns Hopkins University, Baltimore, MD, 21218, USA. goutsias@jhu.edu.

Funding

MOLECULAR PATHOLOGY OF WILMS TUMOR RELATED GENES 11PR01CA054358 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDREW P. FEINBERG · 1991 to 2026
$5.5M
Epigenetic Drivers of Intrinsic Phenotypic Variability in Metabolic DiseaseDP1DK119129 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI FEINBERG, ANDREW P. · 2018 to 2023
$3.9M
National Science Foundation EFRI CEE 132452NCI NIH HHS R01 CA054358NIDDK NIH HHS DP1 DK119129
6 · The paper itself

Abstract

High-throughput third-generation nanopore sequencing devices have enormous potential for simultaneously observing epigenetic modifications in human cells over large regions of the genome. However, signals generated by these devices are subject to considerable noise that can lead to unsatisfactory detection performance and hamper downstream analysis. Here we develop a statistical method, CpelNano, for the quantification and analysis of 5mC methylation landscapes using nanopore data. CpelNano takes into account nanopore noise by means of a hidden Markov model (HMM) in which the true but unknown ("hidden") methylation state is modeled through an Ising probability distribution that is consistent with methylation means and pairwise correlations, whereas nanopore current signals constitute the observed state. It then estimates the associated methylation potential energy function by employing the expectation-maximization (EM) algorithm and performs differential methylation analysis via permutation-based hypothesis testing. Using simulations and analysis of published data obtained from three human cell lines (GM12878, MCF-10A, and MDA-MB-231), we show that CpelNano can faithfully estimate DNA methylation potential energy landscapes, substantially improving current methods and leading to a powerful tool for the modeling and analysis of epigenetic landscapes using nanopore sequencing data.

Indexed as

AlgorithmsDNA MethylationEpigenesis, GeneticBreast NeoplasmsCells, CulturedFemaleGenome, HumanHumansLymphocytesNanopore SequencingSequence Analysis, DNA

Identifiers

PMID34732768
PMCPMC8566571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.